Company profile: Cervel Neurotech
1.1 - Company Overview
Company description
- Provider of medical device solutions for non-invasive deep brain neuro-modulation, pioneering an innovative, proprietary approach based on repetitive transcranial magnetic stimulation (rTMS).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cervel Neurotech
Pharnext
HQ: France
Website
- Description: Provider of clinical-stage biopharmaceutical therapeutics for severe neurodegenerative diseases, developing PXT3003 for Charcot-Marie-Tooth disease type 1A using its Pleotherapy approach (Phase III), and PXT864, a fixed-dose combination of baclofen and acamprosate progressing to Phase 2a in ALS; also sponsors CMT&Me, an app-based international study of CMT patient lifestyles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharnext company profile →
Mynd Life Sciences
HQ: Canada
Website
- Description: Provider of biomarker diagnostic tests for postpartum depression and early Alzheimer’s detection, psilocybin-based drug R&D targeting central nervous system diseases, and intellectual property on inflammation-regulating gene pathways to support treatments for neuroinflammatory diseases; also developing at-home tests to monitor inflammation and aid health management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mynd Life Sciences company profile →
Lobe Sciences
HQ: Canada
Website
- Description: Provider of life sciences focused on transformational medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lobe Sciences company profile →
AlzProtect
HQ: United States
Website
- Description: Provider of biopharmaceutical drug candidates and clinical development for neurodegenerative diseases, including Alzheimer’s disease and orphan tauopathies such as Progressive Supranuclear Palsy. Offers AZP2006 with a unique mechanism targeting amyloid toxicity, Tau phosphorylation, oxidative stress, and neuroinflammation; conducts clinical trials and partners with pharmaceutical companies for marketing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AlzProtect company profile →
PAQ Therapeutics
HQ: United States
Website
- Description: Provider of an autophagy-based drug discovery platform using ATTEC autophagosome-tethering compounds to degrade disease-causing proteins, lipids, and other substrates. Collaborates with Insilico Medicine to develop small molecule therapies via AI-driven drug discovery, with initial work in a genetic neurodegenerative disorder and plans to expand to diseases lacking treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PAQ Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cervel Neurotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cervel Neurotech
2.2 - Growth funds investing in similar companies to Cervel Neurotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cervel Neurotech
4.2 - Public trading comparable groups for Cervel Neurotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →